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AMPK-SIRT1-PGC-1a SIGNALING REGULATES MITOCHONDRIAL
FUNCTION IN HUMAN ARTICULAR CHONDROCYTES
X. Zhao y, R. Terkeltaub y, M. Lotz z, R. Liu-Bryan y. yVAMC, UCSD, San
Diego, CA, USA; z The Scripps Res. Inst., San Diego, CA, USA
Purpose:Mitochondrial dysfunction in chondrocytes is associated with
osteoarthritis (OA), and impacts pathways implicated in cartilage
degradation, for example, by promoting oxidative stress and increasing
inﬂammatory cytokine-induced chondrocyte inﬂammation and matrix
catabolism. AMPK is a master regulator of cellular energy homeostasis.
We have previously reported that AMPK activity is reduced in human
knee OA articular chondrocytes. IL-1b, TNFa, and biomechanical injury
decrease AMPK activity in chondrocytes. In addition, AMPK pharma-
cologic activators suppress chondrocyte catabolic responses to inﬂam-
matory cytokines. Recent studies have demonstrated that SIRT1,
a nicotinamide adenine dinucleotide (NAD)-dependent protein deace-
tylase as another fuel-sensing molecule, also plays an important role in
cartilage matrix homeostasis. AMPK and SIRT1 share some common
target molecules involved in mitochondrial function including PGC-1a,
a master regulator of mitochondrial biogenesis. Therefore, we tested the
hypothesis that AMPK and SIRT1 coordinate to regulate mitochondrial
function in human articular chondrocytes, which contributes to regu-
lation of matrix metabolism.
Methods: Primary human knee chondrocytes treated with AMPK
pharmacologic activators AICAR (1 mM) and A-769662 (0.5 mM),
primary mouse chondrocytes isolated from femoral head cartilages of
AMPKa1 knockout (KO) and wild type (WT) mice, or primary human
knee chondrocytes transfected with SIRT1 or PGC-1a siRNA (Invitrogen)
were subjected to Western blot analyses for phosphorylation and
expression of AMPKa, expression of SIRT1 and PGC-1a. NAD/NADH ratio
and mitochondrial biogenesis such as expression of PGC-1a and mito-
chondrial transcriptional factor A (TFAM), a major transcriptional factor
governing mitochondrial DNA replication and transcription during
mitochondrial biogenesis) were assessed in chondrocytes stimulated
with AICAR and A-769662 by a NAD/NADH quantiﬁcation assay (Bio-
vision) and RT-PCR for mRNA expression of PGC-1a and TFAM,
respectively. The conditionedmedia of human knee chondrocytes in the
presence or absence of AICAR or A-769662, or the PGC-1a knockdown
chondrocytes stimulated with IL-1b (10 ng/ml) and TNFa (20 ng/ml)
was used for measuring nitric oxide (NO) generation and release of
MMP-3 and -13 by Griess reaction and ELISA, respectively.
Results: AMPK pharmacologic activators (AICAR or A-769662) pre-
vented oxidative stress by up-regulating expression of the anti-oxidant
enzymes SOD2 and catalase, effects dependent on PGC-1a. We observed
induction of NAD+/NADH ratio and SIRT1 expression in human chon-
drocytes stimulated with AICAR or A-769662. Conversely, inhibition of
SIRT1 expression was seen in AMPKa1 KO mouse chondrocytes.
However, knockdown of SIRT1 in human chondrocytes did not alter
phosphorylation and expression of AMPKa, but impaired PGC-1a
protein expression, suggesting that SIRT1 was downstream of AMPK but
upstream of PGC-1a. In addition, AICAR or A769662 promoted mito-
chondrial biogenesis, as evidenced by increased PGC-1a and TFAM
mRNA expression. These effects were linked to near complete inhibition
of catabolic responses, including >90% decreased release of NO and
MMP-3 andMMP-13 in chondrocytes (P< 0.01 for all) in response to IL-
1b and TNFa. Opposite results, with signiﬁcantly increased release of
NO, MMP-3 and MMP-13 (P<0.01) were observed in the PGC-1a
knockdown chondrocytes.
Conclusions: AMPK-SIRT1-PGC-1a signaling regulates mitochondrial
function by promoting mitochondrial biogenesis, decreasing oxidative
stress in chondrocytes. These effects contribute to attenuation, by
AMPK, of catabolic chondrocyte responses to inﬂammatory cytokines.
These ﬁndings provide a novel molecular mechanism by which phar-
macologic activation of AMPK has translational potential to inhibit
progression of cartilage degradation in OA.230
MANGANESE SUPEROXIDE DISMUTASE DEFICIENCY IN
CHONDROCYTES INDUCES MITOCHONDRIAL SUPEROXIDE
GENERATION LEADING TO IMPAIRED PROLIFERATION AND MATRIX
PRODUCTION, BUT NOT APOPTOSIS
M. Koike y,z, H. Nojiri z, Y. Saita z, D. Morikawa y,z, K. Kobayashi y,z,
K. Watanabe y, K. Kaneko z, T. Shimizu y. yDept. of Advanced AgingMed., Chiba Univ. Graduate Sch. of Med., Chiba, Japan; zDept. of
Orthopedics, Juntendo Univ. Graduate Sch. of Med., Tokyo, Japan
Purpose: Manganese superoxide dismutase (Sod2) is a major antioxi-
dant enzyme localized in the mitochondria, which diminish mito-
chondrial superoxide. It has been reported that mitochondrial SOD2
was signiﬁcantly down-regulated in the superﬁcial layer of OA cartilage
(Ruiz-Romero et al. Mol. Cell. Proteomics, 2009, Scott et al. Ann. Rheum.
Dis., 2010). However, it has been unclear how Sod2 insufﬁciency affected
physiological function of chondrocytes. Here, we investigated to clarify
the biological consequence of Sod2 deﬁciency and mitochondrial
superoxide generation in chondrocytes.
Methods: In order to investigate the effect of mitochondrial oxidative
stress, we generated Sod2-deﬁcient chondrocytes isolated from artic-
ular cartilage of newborn mice using tamoxifen-inducible cre-loxp
system (Rosa26-CreERT2tg/wt,Sod2ﬂox/ﬂox). Mitochondrial superoxide was
examined by dihydroethidium staining for ﬂow cytometry (FACS).
Cellular phenotypes of Sod2 deﬁciency in articular chondrocytes were
evaluated by cell number and proliferation via BrdU incorporation. To
investigate whether mitochondrial superoxide induces apoptosis,
apoptotic analyses were performed by annexin-V/PI staining and
western blot of caspase-3. To determine whether mitochondrial
superoxide leads to dysfunction in chondrocytes, expression of chon-
drocyte markers was performed by real time qPCR. Finally, we evalu-
ated extracellular matrix (ECM) in Sod2-deﬁcient chondrocytes using
alcian blue staining.
Results: Tamoxifen treatment decreased SOD2 protein at culture day 3,
and completely depleted SOD2 protein at culture day 6. Mitochondrial
superoxide generation was increased by 2.5-fold in Sod2-deﬁcient
chondrocytes compared with controls at culture day 6. There was no
signiﬁcant difference in cell number between Sod2-deﬁcient chon-
drocytes and controls at culture day 3, while total cell number of Sod2-
deﬁcient chondrocytes was signiﬁcantly decreased by 39% compared
with controls at culture day 6. However, we failed to ﬁnd increased
apoptotic cells. Cell proliferation in Sod2-deﬁcient chondrocytes was
suppressed by 35%, indicating that mitochondrial superoxide leads to
impaired cell proliferation without inducing apoptosis. In gene
expression analysis, anabolic genes including Sox9, Col2a1, and Acan
were signiﬁcantly down-regulated, while catabolic genes including
Mmp13 and Adamts5 were signiﬁcantly up-regulated. Moreover, alcian
blue staining of proteoglycans revealed a signiﬁcant decreased by 85%
in Sod2-diﬁcient chondrocytes at culture day 21.
Conclusions: These results revealed that Sod2 deﬁciency in chon-
drocytes induces mitochondrial superoxide generation leading to
impaired cell proliferation, but not apoptosis. Moreover, Sod2 deﬁciency
also decreased ECM production with imbalance between matrix
synthesis and degradation, suggesting that mitochondrial superoxide
plays a pivotal role in OA progression.231
INHIBITION OF COG5, A GENE FROM THE C7Q22 OSTEOARTHRITIS
SUSCEPTIBILITY LOCUS, INDUCES GLYCOSYLATION DEFECTS AND
AFFECTS CHONDROGENESIS AND OSTEOGENESIS BY DISTURBING
WNT SIGNALING
F. Cailotto, R.J. Lories;. KU Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is a highly disabling pathology of the
bone-cartilage unit, to which both patient-dependent (weight excess,
trauma/) and genetic factors contribute. Recently, a locus at chromo-
some 7q22 was linked to knee and hand OA by genome wide associa-
tion study. In this locus, the Conserved oligomeric Golgi complex
subunit (COG) 5 gene encodes a component of Golgi apparatus. Muta-
tions in humans are associated with mild congenital glycosylation
disorders, and COG5 expression is higher in 3D than in monolayer
cultures of articular chondrocytes. Here we investigated on the role of
COG5 during chondrogenesis and osteogenesis.
Methods: We used three independent stable clonal colonies of each,
controls (non-sliencing vector) and COG5 knocked-down cells (COG5-),
established in the chondrogenic ATDC5 and osteogenic MC3T3-E1 cell
lines. ATDC5 were cultured as high density micromasses (2x105 cells/
10 ml) to mimic the condensation step of developing cartilage. Chon-
drogenesis was induced by culturing cells for 14 days (D) in DMEM/F12
+ 5%FBS, supplemented with ITS (insulin, transferrin, sodium selenite).
On D14, cells were switched tomineralization medium (aMEM + 5%FBS,
supplemented with ITS, b-glycerophosphate (BGP) and ascorbic acid
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Monolayers of MC3T3-E1 were cultured for 21D in aMEM + 10%FBS,
supplemented with BGP and AA. mRNA expression of typical chon-
drogenesis markers (Aggrecan (Agg), type II (Col2a1) and X (Col10a1))
collagens and osteogenic markers (Osterix (Osx), Osteocalcin (Ocn) and
Osteopontin (Opn)) were assessed by quantitative RT-PCR. We also
assessed mRNA expression of Wnts (-4, -5a, -5b, -11) and BMPs (-2, -4,
-6, -7). Quantiﬁcation of Alcian Blue, Safranin O, Sirius red and Alizarin
red staining were used to evaluate proteoglycans, collagens and
mineralized content respectively. Alkaline phosphatase (ALP) activity
allowed to monitor osteogenesis. SDS-PAGE was used to assess the
global glycosylation status. Western blot allowed to check canonical (b-
catenin) and non-canonical (Calmodulin-Kinase II) Wnt signaling, as
well as BMP signaling (Smad and MAPK).
Results: During early proliferation (D1-7) and late proliferation/pre-
hypertrophy phases (D7-14) of chondrogenesis, Col2a1 and Agg mRNA
strongly increased, but to a lesser extent in COG5-. Proteoglycan
staining intensity was lower in COG5-. BMP-4 levels progressively
increased and were signiﬁcantly higher in COG5-. This was consistent
with increased phosphorylation of Smad 1/5/8. Wnt-4, -5a and -5b
mRNA were evenly increased in both controls and COG5-. BMP-6 and
Col10a1 mRNA were increased at D14, but were signiﬁcantly lower in
COG5-. Wnt-11 mRNA increased in controls, but not in COG5-. In
mineralization phase (D14 to D21), Col10a1 mRNA and mineralization
were strongly increased, but to a lesser extent in COG5-. During
osteogenesis, Opn, Osx and Ocn mRNA were signiﬁcantly higher in
controls, alike Alizarin red staining and ALP activity. Protein analysis
suggested differences in global glycosylation status, in particular of Wnt
ligands.
Conclusions: COG5 defect reduces chondrogenesis and osteogenesis.
COG5 particularly affected glycosylation andWnt signaling, underlining
its critical role in the fate of cells from the articular chondrocyte-bone
unit in the course of OA.232
ROLE OF INTERLEUKIN-10 IN ENDOCHONDRAL BONE FORMATION
G. Kim y,z, Y.-K. Jung z, H.-R. Park z, E.-J. Lee z, J.-Y. Choi x, F. Beier {,k,
S.-W. Han y,z. yDept. of Rheumatology, Daegu Fatima Hosp., Daegu,
Republic of Korea; z Lab. for Arthritis and Bone Biology, Fatima Research
Inst., Daegu, Republic of Korea; xDept.s of Biochemistry and Cell Biology,
Sch. of Med., WCU program, Kyungpook Natl. Univ., Daegu, Republic of
Korea; kDept. of Physiology and Pharmacology, Univ. of Western
Ontario, London, ON, Canada; {Children's Hlth.Res. Inst., London, ON,
Canada
Purpose: Interleukin-10 (IL-10) is a pleiotrophic immunoregulatory
cytokine that has been shown to be elevated in cartilage and synovium
of osteoarthritis and has a chondroprotective effect. However, the role
of IL-10 during endochondral bone formation has not been well eluci-
dated. We intended to investigate the effect of IL-10 on endochondral
bone formation.
Methods: Loss- and gain of IL-10 function in endochondral bone
formation was studied with IL-10 null mice and IL-10-treated E15.5
tibia organ cultures, respectively. Primary chondrocytes from long
bones of E15.5 mice were cultured with or without IL-10 (10 ng/ml),
and the effects of IL-10 on chondrocyte marker genes or proteins were
assessed by real-time polymerase chain reaction and Western blot
analysis. Proliferation of primary chondrocytes was determined by
MTT assay.
Results:Whole skeletal stain of IL-10 null mice did not show signiﬁcant
difference in gross development compared with WT littermates, except
reduced occipital bone formation. Treatment with IL-10 signiﬁcantly
increased the length of tibiae in organ culture. IL-10 caused an increase
of both proliferating and hypertrophic zone length compared to control
group, but the proportion of either zone relative to total growth plate
length was not different between IL-10-treated and control groups. IL-
10 induces chondrogenic and hypertrophic differentiation as well as
proliferation of chondrocytes in vitro. Real-time PCR data revealed that
IL-10 treatment resulted in slight but signiﬁcant increases in the mRNA
expression of both chondrogenic and hypertrophic marker genes,
including aggrecan, type 2 collagen, type 10 collagen, osteopontin, and
MMP-13. Also, IL-10 increased the expression of Sox9 and Runx2 at m-
RNA and protein level. MTT assay showed that IL-10 signiﬁcantly
increased a proliferation of chondrocytes.Conclusions: These data represent the ﬁrst evidence that IL-10 induces
the chondrogenesis, chondrocyte proliferation and hypertrophic
differentiation through Sox9 and Runx2.233
DYSREGULATED FOXO TRANSCRIPTION FACTORS IN ARTICULAR
CARTILAGE IN AGING AND OSTEOARTHRITIS
Y. Akasaki y, R. Liu-Bryan z, R. Terkeltaub z, M. Lotz y. y The Scripps Res.
Inst., La Jolla, CA, USA; zUniv. of California San Diego, La Jolla, CA, USA
Background/Purpose: Aging-associated changes in articular chon-
drocytes represent a major risk factor for cartilage degradation and
osteoarthritis (OA). The major signaling pathway that regulates cellular
aging and stress resistance is the Insulin/IGF-1 signaling pathway. In
this pathway, Forkhead-box class O (FoxO) transcription factors play
central roles in protein quality control, autophagy and cellular defenses
against oxidative stress. The objective of this study was to analyze
expression and activation of FoxO transcription factors in normal, aging
and OA cartilage.
Methods: Human knee joints from individuals ages 23-90 were ob-
tained at autopsy. The entire femoral condyles of knee joints were
harvested from 6 young normal donors (mean  SD ¼ 36.0  9.6 years
old, OA grade I). Aged knee joints were also obtained from 4 donors
(mean  SD ¼ 72.5  3.6 years) with no history of arthritis and normal
or minimally ﬁbrillated cartilage (OA grade I-II). OA human joints were
obtained from 4 donors (mean  SD ¼ 81.5  10.3 years, OA grade III-
IV). Knee joints were also obtained frommice at the age of 4, 12, and 24
months and following surgically induced OA. Expression of FoxO
proteins was analyzed by immunohistochemistry and western blotting.
Regulation of FoxO protein expression and activation was analyzed in
cultured chondrocytes stimulated with cytokines, growth factors and
oxidants.
Results: Human cartilage expressed predominantly FoxO1 and FoxO3
but not FoxO4 protein as detected by western blotting. Immunohis-
tochemistry showed that normal human articular cartilage expressed
FoxO1 and FoxO3 proteins more strongly in chondrocytes in the
superﬁcial and mid zone as compared to the deep zone. FoxO showed
mainly nuclear localization in young normal cartilage. Areas of
cartilage exposed to minimal versus maximal weightbearing showed
no signiﬁcant difference in young normal cartilage except for the
deep zone where FoxO3 was more strongly expressed. During human
joint aging, expression of FoxO1 and FoxO3 was markedly reduced in
the superﬁcial zone of cartilage regions exposed to maximal
weightbearing. In OA-affected cartilage, chondrocyte clusters showed
strong FoxO phosphorylation and cytoplasmic localization. Similar
patterns of FoxO expression in normal joints and changes in aging
and OA joints were observed in mouse models. In cultured chon-
drocytes, the longer-term (2-5 day) treatment with proinﬂammatory
cytokines IL-1b and TNF-a suppressed FoxO1 protein, while TGF-
b and PDGF increased FoxO1 and FoxO3 expression, respectively.
FoxO1 and FoxO3 phosphorylation was increased signiﬁcantly by
short-term (60 minutes) exposure to IL-1b, PDGF, b-FGF, IGF-1, and
the oxidant t-BHP.
Conclusions: Normal articular cartilage has a tissue speciﬁc signature of
FoxOs expression and activation. Aging and OA in humans and mice is
associated with profound changes in FoxO expression and activation.
These results suggest that changes in FoxO expression and activation
may be involved in cartilage aging and OA, and provide a foundation
upon which the function of FoxOs in cartilage homeostasis, aging and
OA can be examined.234
NEUROPEPTIDE REGULATION OF CHONDROCYTE GENE EXPRESSION
D. Bevan y, M.B. Goldring z, I. Clark y, S. Donell x, J. Gavrilovic y. yUniv. of
East Anglia, Norwich, Norwich, United Kingdom; zWeill Cornell Med.
Coll., NY, USA; xNorfolk and Nowich Univ. Hosp., Norwich, United Kingdom
Purpose: Damaged cartilage is increasingly recognised as a permissive
environment for neurovascular inﬁltration. Neuropeptides involved in
pain transmission in osteoarthritis, have recently been implicated in
cartilage breakdown and also in chondrocyte proliferation and
survival. We took an unbiased approach to explore the effect of
substance P and bradykinin on expression 95 genes which may be
important in cartilage breakdown including all members of the MMP,
